Biotech
MANCHESTER, UNITED KINGDOM: MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 04/08/13 -- Epistem Plc. (LSE: EHP), the UK biotechnology and personalised medicine company, today announced it will be presenting advances in two inde ...
CAMBRIDGE, MA: Data to Be Presented at the Muscular Dystrophy Association Scientific Conference ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 04/05/13 -- Sernova Corp. (TSX VENTURE: SVA) announced further to the completion of the non-brokered private placement on February 19, 2013, consisting of 10,000, ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/04/13 -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28 ...
PALATINE, IL: Further Expands Patent Estate Covering Abuse Deterrent Forms of Opioid Analgesics and Certain Other Active Pharmaceutical Ingredients ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 04/04/13 -- Regen BioPharma, Inc. (Regen), a wholly-owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), provided an update on the Company's pro ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/04/13 -- (NASDAQ: PRAN) (ASX: PBT) today reported that it has received a A$2.5 million cash refund under the R&D Tax Incentive Program, a program admin ...
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/04/13 -- IDT Australia Ltd (ASX: IDT) is pleased to announce the appointment of Dr. Paul MacLeman as Chief Executive Officer of the Company, effective from ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 04/04/13 -- Vital Therapies, Inc., a development-stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver fa ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 04/04/13 -- Aragon Pharmaceuticals Inc., a leader in developing drugs for hormone driven cancers, today announced that the first patient has been dosed in a Phase I ...
VANCOUVER, BRITISH COLUMBIA: Positive Phase IIa Results Attract Additional Funds and New Syndicate Member to Advance Clinical Development and Strengthen Management Team ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/03/13 -- Arch Biopartners Inc ("Arch" or the "Company") (CNSX: ACH)(OTCBB: FOIFF) today announced that Arch scientists have co-authored a ...
VANCOUVER, BRITISH COLUMBIA: Positive Phase IIa Results Attract Additional Funds and New Syndicate Member to Advance Clinical Development and Strengthen Management Team ...
DENVER, CO: DENVER, CO -- (Marketwired) -- 04/03/13 -- , the leader in the field of rapid virus quantification, today announced the addition of new investors to its most recent round of funding. This financing w ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/03/13 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) is pleased to announce that its majority-owned subsidiary, Agrisoma Biosciences Inc. ("Agr ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 04/03/13 -- Theratechnologies Inc. (TSX: TH) today announced the signature of an amended lease agreement with its lessor which will result in a 1.2 million dolla ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 04/02/13 -- Critical Outcome Technologies Inc. (COTI or the Company) (TSX VENTURE: COT) is pleased to announce today that it has retained Venture Liquidity Provid ...
TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 04/01/13 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diag ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 04/01/13 -- Arch Biopartners Inc. ("Arch" or the "Company") (CNSX: ACH)(OTCBB: FOIFF) today announced that the Company received approval from ...
